Published in

Wiley, International Journal of Cancer, 1(74), p. 57-63, 1997

DOI: 10.1002/(sici)1097-0215(19970220)74:1<57::aid-ijc10>3.0.co;2-f

Links

Tools

Export citation

Search in Google Scholar

Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO